Ellen J. Scherl, M.D.
Gastroenterology

About
Personal Statement
Ellen J. Scherl, M.D. is the Jill Roberts Professor of Inflammatory Bowel Disease at Weill Cornell Medicine. She is currently an Attending Physician at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Dr. Scherl is a world-renowned expert in Inflammatory Bowel Disease specializing in Crohn's Disease and Ulcerative Colitis. Dr. Scherl has an active practice and serves as a principal investigator on many clinical trials on Crohn's Disease and Ulcerative Colitis. As part of Dr. Scherl's comprehensive approach to patient care, she closely collaborates with world renowned IBD surgical team lead by experts Dr. Fabrizio Michelassi and Dr. Jeffrey Milsom, complimented by Dr. Toyoki Sonoda. The team is known for innovative surgical approaches including laparoscopic and endoscopic techniques as well as bowel sparing surgeries. Dr. Oscar Lebwohl of The New York-Presbyterian Hospital - Columbia Campus also works closely with Dr. Scherl in her efforts.
The Jill Roberts Center for Inflammatory Bowel Disease is exploring ways of integrating healthcare and IBD research looking forward to achieving preventive and personalized medicine. The IBD Center is committed to the interdisciplinary approach to Inflammatory Bowel Disease focusing on nutrition, osteoporosis, nephrology, dysplasia, and colon cancer screening using novel techniques such as narrow band imaging. Dr. Scherl frequently lectures on Inflammatory Bowel Disease at local, regional and national meetings, conferences and seminars.
Specialties and Expertise
Specialties
- Gastroenterology
Expertise
- Crohn's Disease
- Inflammatory Bowel Diseases (IBD)
- Endoscopy
- Ulcerative Colitis
- Colonoscopy
- Clinical Research
Biography
Ellen J. Scherl, M.D. is the Jill Roberts Professor of Inflammatory Bowel Disease at Weill Cornell Medicine. She is currently an Attending Physician at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Dr Scherl is the Jill Roberts Professor of Clinical Medicine. She is committed to caring for the community of individuals and families living with Crohn's disease and Ulcerative Colitis while curing IBD through collaborations focusing on individualized medicine by illuminating endoscopic, immunologic, microbial, genetic and molecular signatures and pathways. Since joining the WCMC/NYPH she has established a longitudinal patient database which documents ongoing validated disease activity indices in the individual daily EMR.
She has an active practice and serves as a principal investigator on national and international randomized clinical trials as well as investigator initiated trials evaluating innovative strategies and investigational therapies for Ulcerative Colitis and Crohn's Disease. She lectures nationally and internationally on optimizing IBD therapies and redefining the impact of innovative therapies on existing strategies.
Dr. Scherl established the IBD Center at NY Presbyterian Hospital / Weill Cornell Medicine in 2002 and became the Founding Director of the Jill Roberts Center for IBD (JRC IBD) in 2006. She is currently the Research Director of JRC. She established the JRC along with the late Jill Roberts as a joint labor of love. She has forged inspired collaborations with Weill Medical College of Cornell University, Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian Hospital’s pediatricians, colorectal surgeons, nutritionisits, researchers and multidisciplinary consultants.
The Jill Roberts Center for Inflammatory Bowel Disease is exploring comprehensive approaches toward integrating nutrition, healthcare and IBD research, looking forward to achieving preventive and personalized medicine. The JRC IBD Center is committed to the interdisciplinary approach to Inflammatory Bowel Disease focusing on nutrition, osteoporosis, nephrology, dysplasia, and colon cancer screening using novel techniques such as narrow band imaging.
In collaboration with the Jill Roberts Institute she has established an IBD live cell bank. She has collaborated with researchers at Cornell University to identify a novel E. Coli bacteria associated with Crohn's Disease and continues to collaborate with Weill Medical College of Cornell University/New York-Presbyterian Hospital researchers investigating the immunogenetics and immunobiology of IBD.
Castle Connolly has consistently honored Dr Scherl as one of America's Top Doctors® in 2020 and celebrates New York Metro Top Doctors 15th Anniversary 2020
She is the 2020 honoree for the CCF Humanitarian of the Year Award. She has received the 2012 CCFÀ Woman of the year award 2008 AGA award for Outstanding Women In Science and in 2007 was awarded the NYSGE Florence Lefcourt Distinguished Service Award.
Research
Honors and Awards
Honors and Awards
Crohn's and Colitis Foundation of America Woman of Distinction 1995
NYSGE Florence Lefcourt Distinguished Service Award January 2007
"Does the Degree of Endoscopic Severity in Patients with Crohn's Disease Correlate with Pathologic Findings on Mucosal Biopsy Specimens?" Mendelsohn, R.B., Bramlage, M., Makhoul, Y., Scherl, EJ, Yantiss, R., and Bosworth, B.P.
This was presented as a combination of the Division of the Roberts Center for IBD, the Division of Gastroenterology and Hepatology at New York Presbyterian Hospital, Weill Cornell Medical Center, the Division of Pathology and Laboratory Medicine, and Staten Island University Hospital, Staten Island, New York. This received Honorable mention or poster of distinction by Weill Cornell Medical Center. May 2007
Learn more
Credentials
Board Certifications
- American Board of Internal Medicine
- American Board of Internal Medicine (Gastroenterology)
Clinical and Academic Positions
- Jill Roberts Professor of Inflammatory Bowel Disease - Weill Cornell Medical College, Cornell University
- Adjunct Professor of Clinical Medicine - Columbia University College of Physicians and Surgeons
- Attending Physician - NewYork-Presbyterian Hospital
- Professor of Clinical Medicine - Weill Cornell Medical College, Cornell University
Education and Training
- M.D., New York Medical College, 1977
Insurance
Insurance Plans Accepted
The following represents most of the managed care plans accepted by this doctor. If your insurance carrier does not appear here please contact the doctor’s office as they may have individual contracts not included on this site.
* indicates this doctor is no longer accepting new patients with this insurance plan.
- AETNA - HMO
- AETNA - Medicare
- AETNA - PPO
- Aetna Weill Cornell Employee Managed Care Plan
- Aetna Weill Cornell Employee PPO Plan
- Aetna-NYP - EPO/POS
- Affinity Access
- Affinity Health Plan
- AgeWell New York
- Amida Care
- CIGNA
- Emblem Select Care
- Empire Blue Cross/Blue Shield - Blue Access
- Empire Blue Cross/Blue Shield - Blue Connection
- Empire Blue Cross/Blue Shield - EPO
- Empire Blue Cross/Blue Shield - HMO
- Empire Blue Cross/Blue Shield - Mediblue (Senior)
- Empire Blue Cross/Blue Shield - PPO
- Empire Blue Cross/Blue Shield HealthPlus
- Empire Blue Cross/Blue Shield HealthPlus - CHP
- Fidelis Care
- GHI - CBP
- Health First
- Health Insurance Plan of NY (HIP)
- Health Insurance Plan of NY (HIP) - Medicaid
- Health Insurance Plan of NY (HIP) - Medicare
- Medicare
- Oxford Health Plans - Freedom
- Oxford Health Plans - Liberty
- Oxford Health Plans - Medicare Advantage
- Oxford Health Plans - Metro/Core/Charter
- Rockefeller University - Trustmark
- United Empire
- United Healthcare
- United Healthcare - Community Plan
- United Healthcare - Medicare
- United Healthcare Compass
- VNSNY CHOICE - HMO
- VNSNY CHOICE - Medicare
- WellCare of NY
- WorldWide Medical
Locations and Appointments
External Relationships
External Relationships
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.